COVID-19 Vaccination Significantly Reduced the Risk of Long COVID Symptoms in Large-Scale Study With Over 20 Million Participants
Català et al. - Lancet Respir Med (2024)
Català et al. - Lancet Respir Med (2024)
TL;Dr.: In a study published in The Lancet Respiratory Medicine, Català and colleagues assessed the impact of COVID-19 vaccines on long COVID symptom prevention. Analyzing data from over 20 million vaccinated and unvaccinated individuals across the United Kingdom, Spain and Estonia, the study revealed that receiving at least one dose of any COVID-19 vaccine significantly lowers the risk of long COVID symptoms compared to unvaccinated individuals. When comparing COVID-19 vaccines, having the BNT162b2 as the first vaccine showed a slightly stronger protective effect compared to ChAdOx1. This large-scale study underscores the critical role of vaccination in reducing the risk of persistent symptoms following COVID-19.
Medically Reviewed By: Fernanda Ferreira, PhD (Harvard Medical School)
Updated: March 12, 2024
What to read next on OpenEvidence
Product
Ask OpenEvidenceFeed
Company
AboutAnnouncements
Contact Us
EmailTwitter

Don′t miss our weekly email alert. Stay up to date on all the new findings that matter.

We care about your privacy. View our terms of use.

© OpenEvidence 2024. All rights reserved.

Terms of Use
Privacy Policy
Advertising Policy

OpenEvidence is an experimental technology demonstrator. OpenEvidence does not provide medical advice, diagnosis or treatment. User questions and other inputs on OpenEvidence are not covered by HIPAA. It is the responsibility of the user to ensure questions do not contain protected health information (PHI) or any information that violates the privacy of any person.